The new inhaled insulin could be available this year possibly. Eli Lilly purchased the product from Locemia Solutions. The glucagon inhaled nebulizer can now be used by the patient and not a caregiver. There is no mixing so it can be administered more rapidly. It is now in a phase 3 study. Check it out in item #5.